This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Activation of Notch receptor signaling in smooth muscle cells (SMC) leads to dysregulated cell cycle progression with features similar to cell transformation. We developed a highly innovative approach employing a gastrointestinal stromal tumor (GIST) model, to address fundamental issues surrounding smooth muscle cell development and differentiation. While the GIST is not thought to be a pure SMC tumor, this is a unique differentiation model because transformation potentially occurs in a precursor cell that gives rise to both SMC and cells of Cajal. GIST express smooth muscle actin and desmin and are characterized by activated c-kit. This study will test a model whereby c-kit activation leads to regulation of Notch signaling, which in turn impacts p27 and cell cycle progression. This project will benefit from collaborative interactions with B. Eisenberg, (Dartmouth), D. Wojchowski (MMCRI) and A. Godwin (Fox Chase Cancer Center). Projects 1 and 2 will be highly interactive since Cthrc1 may be a marker for GIST and play a regulatory role in invasion and angiogenesis. In addition, interaction with Project 3 (C. Vary) is anticipated since this project will be investigating blood vessel recruitment, which will be relevant to GIST angiogenesis. Interactions with R. Friesel are expected since the Spry and Spred family of Ras pathway inhibitors are likely to impact the c-kit pathway. Lastly, an anticipated interaction is expected with Project 4 (I. Prudovsky) studying inflammatory reactions of GIST. This project will utilize all cores and interact highly with Project 6, using MRI to monitor GIST tumor phenotype non-invasively.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR015555-08
Application #
7609692
Study Section
Special Emphasis Panel (ZRR1-RI-8 (01))
Project Start
2007-05-01
Project End
2008-02-29
Budget Start
2007-05-01
Budget End
2008-02-29
Support Year
8
Fiscal Year
2007
Total Cost
$188,078
Indirect Cost
Name
Maine Medical Center
Department
Type
DUNS #
071732663
City
Portland
State
ME
Country
United States
Zip Code
04102
Soley, Luna; Falank, Carolyne; Reagan, Michaela R (2017) MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells. Curr Osteoporos Rep 15:162-170
Young, K; Krebs, L T; Tweedie, E et al. (2016) Endoglin is required in Pax3-derived cells for embryonic blood vessel formation. Dev Biol 409:95-105
Ames, Jacquelyn J; Contois, Liangru; Caron, Jennifer M et al. (2016) Identification of an Endogenously Generated Cryptic Collagen Epitope (XL313) That May Selectively Regulate Angiogenesis by an Integrin Yes-associated Protein (YAP) Mechano-transduction Pathway. J Biol Chem 291:2731-50
Contois, Liangru W; Akalu, Abebe; Caron, Jennifer M et al. (2015) Inhibition of tumor-associated ?v?3 integrin regulates the angiogenic switch by enhancing expression of IGFBP-4 leading to reduced melanoma growth and angiogenesis in vivo. Angiogenesis 18:31-46
Motyl, Katherine J; Bishop, Kathleen A; DeMambro, Victoria E et al. (2013) Altered thermogenesis and impaired bone remodeling in Misty mice. J Bone Miner Res 28:1885-97
Apra, Caroline; Richard, Laurence; Coulpier, Fanny et al. (2012) Cthrc1 is a negative regulator of myelination in Schwann cells. Glia 60:393-403
Contois, Liangru W; Nugent, Desiree P; Caron, Jennifer M et al. (2012) Insulin-like growth factor binding protein-4 differentially inhibits growth factor-induced angiogenesis. J Biol Chem 287:1779-89
Urs, Sumithra; Henderson, Terry; Le, Phuong et al. (2012) Tissue-specific expression of Sprouty1 in mice protects against high-fat diet-induced fat accumulation, bone loss and metabolic dysfunction. Br J Nutr 108:1025-33
Sathyanarayana, Pradeep; Dev, Arvind; Pradeep, Anamika et al. (2012) Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2. Blood 119:5522-31
Motyl, Katherine J; Dick-de-Paula, Ingrid; Maloney, Ann E et al. (2012) Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain. Bone 50:490-8

Showing the most recent 10 out of 101 publications